ISSN 0303-5212
 

Original Research 
RMJ. 2015; 40(3): 325-330


What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?

Shahid Sarwar, Shandana Tarique.

Abstract
Objective: To identify variables associated with poor performance status of hepatocellular carcinoma (HCC) patients and to compare impact of stage of liver disease and that of hepatoma on functional status of patient.
Patients and Methods: We included 254 confirmed cases of liver cancer in a cross sectional analytical study carried out at Doctors Hospital Lahore. Patient’s clinical, biochemical and radiological variables were correlated with Karnofsky’s performance status (KPS) using pearson correlation. Model for End stage Liver Disease (MELD) and Cancer of Liver Italian Program (CLIP) were evaluated for predicting performance status using Receiver Operating Characteristic (ROC) curve.
Results: Mean age of patients was 56.69 (±10.34) and male to female ratio was 2.47: 1 (181/73). On KPS evaluation 84 (33.1%) patients scored between 80-100, 147 (57.9%) had score of 50-70 while in 23 (9.1%) KPS score was between 0-40. Variables associated with poor performance status were bilirubin> 3mg/dl (p value 0.00), albumin< 2.5 g/dl (p value 0.00), creatinine > 1.2mg/dl (p 0.00), prothrombin time> 16seconds (p value 0.00), size of tumor >7cm (p value 0.02), tumor involving > 50% of liver mass (p value 0.00) and vascular invasion (p value 0.00). Both stage of liver disease as determined by MELD and stage of liver cancer as per CLIP scores had strong correlation (p value 0.00) with poor performance status of patient. Area under ROC curve was 0.764 for MELD score and 0.785 for CLIP score.
Conclusion: Performance status of liver cancer patients is affected by both stage of liver disease and that of liver tumor. Patients with MELD score above 16 and CLIP score above 4 have poor performance status

Key words: Hepatocellular carcinoma, Karnofsky’s performance status, Predictors, stage of liver tumor


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shahid Sarwar
Articles by Shandana Tarique
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Shahid Sarwar, Shandana Tarique. What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. RMJ. 2015; 40(3): 325-330.


Web Style

Shahid Sarwar, Shandana Tarique. What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. https://www.rmj.org.pk/?mno=168334 [Access: December 07, 2023].


AMA (American Medical Association) Style

Shahid Sarwar, Shandana Tarique. What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. RMJ. 2015; 40(3): 325-330.



Vancouver/ICMJE Style

Shahid Sarwar, Shandana Tarique. What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. RMJ. (2015), [cited December 07, 2023]; 40(3): 325-330.



Harvard Style

Shahid Sarwar, Shandana Tarique (2015) What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. RMJ, 40 (3), 325-330.



Turabian Style

Shahid Sarwar, Shandana Tarique. 2015. What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. Rawal Medical Journal, 40 (3), 325-330.



Chicago Style

Shahid Sarwar, Shandana Tarique. "What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?." Rawal Medical Journal 40 (2015), 325-330.



MLA (The Modern Language Association) Style

Shahid Sarwar, Shandana Tarique. "What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?." Rawal Medical Journal 40.3 (2015), 325-330. Print.



APA (American Psychological Association) Style

Shahid Sarwar, Shandana Tarique (2015) What effects more the performance status of patients with hepatocellular carcinoma: stage of tumor versus underlying liver disease status?. Rawal Medical Journal, 40 (3), 325-330.